title: Role of infliximab in ulcerative colitis: further questions.
authors.forename: Charles W
authors.initials: CW
authors.lastname: Lees
authors.forename: Alan G
authors.initials: AG
authors.lastname: Shand
authors.forename: Ian D
authors.initials: ID
authors.lastname: Penman
authors.forename: Jack
authors.initials: J
authors.lastname: Satsangi
authors.forename: Ian D R
authors.initials: ID
authors.lastname: Arnott
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000473:pathology; D003424:Crohn Disease / Q000188:drug therapy* / Q000473:pathology; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab